Opko Health Inc Quick Ratio (OPK) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Opko Health Inc   (NASDAQ: OPK)

Opko Health Inc 's Quick Ratio

OPK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Opko Health Inc 's Cash & cash equivalent grew by % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Opko Health Inc 's Quick Ratio to 2.01, above Opko Health Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 288 other companies have achieved higher Quick Ratio than Opko Health Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 1252.

Explain Quick Ratio?
How much Cash & cash equivalents OPK´s has?
What are OPK´s Current Liabilities?




OPK Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -12.74 % -49.85 % -78.27 % -20 % -22.03 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 2.01 - - - -
OPK's Total Ranking # 1252 # 0 # 0 # 0 # 0
Seq. Current Liabilities Change 0.66 % 4.67 % -16.28 % -1.09 % -42.14 %
Seq. Cash & cash equivalent Change - - - - -



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 289
Healthcare Sector # 500
Overall Market # 1252


Quick Ratio Statistics
High Average Low
4.36 1.01 0.08
(Jun 30 2011)   (Jun 30 2020)




Financial Statements
Opko Health Inc 's Current Liabilities $ 149 Millions Visit OPK's Balance sheet
Opko Health Inc 's Cash & cash equivalent $ 301 Millions Visit OPK's Balance sheet
Source of OPK's Sales Visit OPK's Sales by Geography


Cumulative Opko Health Inc 's Quick Ratio

OPK's Quick Ratio for the trailling 12 Months

OPK Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -54.26 % -54.28 % -39.59 % 58.28 % 65.74 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 0.49 - - - -
Total Ranking TTM # 4067
Seq. Current Liabilities TTM Growth -3.46 % -18.95 % -39.62 % -3.18 % -3.51 %
Seq. Cash & cash equivalent TTM Growth - - - - -


On the trailing twelve months basis OPK Cash & cash equivalent remained unchanged by % in Q2 2026 year on year, while Current Liabilities remained unchanged to $149 millions, this led to